Dicerna Pharmaceuticals' IPO

Dicerna Pharmaceuticals raised a round of funding on January 30, 2014. Investors include Public.

Dicerna Pharmaceuticals is a pharmaceutical company developing RNA interference (RNAi)-based therapeutics against genetically-defined targets in multiple disease areas, including cancer. Dicerna's the…

Articles about Dicerna Pharmaceuticals' IPO: